
Sign up to save your podcasts
Or


Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and accident investigation, at Cranfield University.
Crispr designed gene cutting therapy for some patients with severe sickle cell disease, approved for NHS use.
The ‘godfather of artificial intelligence’ issues stark warning that the technology could one day replace humans.
Also in this episode:
Hosted on Acast. See acast.com/privacy for more information.
By The Evening Standard3.8
55 ratings
Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and accident investigation, at Cranfield University.
Crispr designed gene cutting therapy for some patients with severe sickle cell disease, approved for NHS use.
The ‘godfather of artificial intelligence’ issues stark warning that the technology could one day replace humans.
Also in this episode:
Hosted on Acast. See acast.com/privacy for more information.

863 Listeners

50 Listeners

86 Listeners

599 Listeners

18 Listeners

410 Listeners

227 Listeners

143 Listeners

1 Listeners

22 Listeners

98 Listeners

116 Listeners

15,506 Listeners

19 Listeners

0 Listeners

3,858 Listeners

688 Listeners

907 Listeners

0 Listeners

8 Listeners

2 Listeners

3 Listeners